Decision-Making in Adult Neurology (2ND)

個数:
  • 予約

Decision-Making in Adult Neurology (2ND)

  • 現在予約受付中です。出版後の入荷・発送となります。
    重要:表示されている発売日は予定となり、発売が延期、中止、生産限定品で商品確保ができないなどの理由により、ご注文をお取消しさせていただく場合がございます。予めご了承ください。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 325 p.
  • 言語 ENG
  • 商品コード 9780443278105

Full Description

Now significantly revised and expanded, Decision-Making in Adult Neurology, 2nd Edition, provides nearly 140 evidence-based algorithms that offer practical guidance when encountering patients with neurologic disease, including patients with unfamiliar or complex conditions. Written by expert neurologists for neurologists, internists, emergency medicine physicians, and any specialty that routinely deals with patients with neurologic conditions, this useful handbook encourages clinicians to think systematically and follow a logical sequence through the steps necessary for efficient and effective decision-making. Each algorithm is accompanied by brief text on the facing page that explains the significance of important decision points.

Outlines the key decision points in patient management, providing a wealth of systematic information that ensures you take into account the proper physical signs and test results that will guide your recommendations
Begins with a section on common presenting symptoms and signs (such as headache, weakness, visual loss, or behavioral change) and then discusses specific neurologic conditions-137 diagnostic and treatment algorithms cover the conditions you're most likely to encounter
Contains important updates on the management of headache, multiple sclerosis, and stroke
Includes new diagnostic algorithms for evaluation of patients with papillaedema, myelopathy, Parkinsonism, neurologic side effects of cancer treatment, coma after cardiac arrest, multiple microhemorrhages, and meningeal disorders. Includes new treatment algorithms for managing patients with Alzheimer's disease, diabetic neuropathy, neuromyelitis optica spectrum disorder, hypersomnia, obstructive sleep apnea, and stroke-related vascular risk factors
Provides visual guidance with magnetic resonance images in relevant chapters and videos that support select algorithms
An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date

Contents

1. Initial Headache
2. Chronic Headache
3. Neck Pain
4. Low Back Pain
5. Aphasia
6. Chronic Cognitive Decline
7. Acute Memory Loss
8. Chronic Memory Loss
9. Rapidly Progressive Dementia
10. Delirium
11. Coma
12. Transient Visual Loss
13. Visual Field Loss
14. Visual Hallucinations
15. Ptosis
16. Pupillary Asymmetry (Anisocoria)
17. Diplopia
18. Nystagmus
19. Facial Weakness
20. Acute Vertigo
21. Recurrent Episodic Dizziness
22. Hearing Loss
23. Pulsatile Tinnitus
24. Dysarthria
25. Proximal Weakness
26. Wrist Drop
27. Unilateral Hand Weakness
28. Unilateral Hand Numbness
29. Knee Extension Weakness
30. Unilateral Foot Drop
31. Fasciculations
32. Sensory Disturbance: Pain and Temperature
33.Sensory Disturbance: Vibration and Proprioception
34. Hyperreflexia and Hyporeflexia
35. Multiple Cranial Neuropathies
36. Ataxia
37. Difficulty Walking
38. Bladder Dysfunction
39. Transient Loss of Consciousness
40. Transient Ischemic Attack
41. Acute Ischemic Stroke
42. Malignant Middle Cerebral Artery Infarction
43. Large Cerebellar Infarction
44. Prevention of Recurrent Ischemic Stroke
45. Ischemic Stroke in the Young
46. Patent Foramen Ovale and Ischemic Stroke
47. Spinal Cord Infarction
48. Asymptomatic Carotid Stenosis
49. Preoperative Neurovascular (Carotid) Clearance
50. Acute Spontaneous Intracerebral Hemorrhage
51. Intracerebral Hemorrhage in the Young
52. Intracerebral Hemorrhage Due to Anticoagulant Therapy
53. Restarting Antithrombotic Therapy After Intracerebral Hemorrhage
54. Subarachnoid Hemorrhage
55. Unruptured Intracranial Aneurysm
56. Vascular Malformations
57. Cerebral Venous Sinus Thrombosis
58. Brain Death
59. Management of Increased Intracranial Pressure
60. Management of Neuromuscular Respiratory Failure
61. Paroxysmal Sympathetic Hyperactivity
62. Traumatic Brain Injury
63. Concussion
64. Postconcussive Syndrome
65. Migraine Headache: Acute Treatment
66. Migraine Headache: Prophylactic Treatment
67. Trigeminal Autonomic Cephalalgias: Treatment
68. Trigeminal Neuralgia
69. Intracranial Hypotension
70. Evaluation of Adult With First Seizure
71. Initial Treatment of Epilepsy
72. Drug-Resistant Epilepsy
73. Antiepileptic Drug Selection
74. Status Epilepticus
75. Management of Comorbidities in Patients With Epilepsy
76. EEG Interpretation
77.Hypersomnia
78. Insomnia
79. Restless Legs Syndrome
80. Parasomnias
81. Abnormal Involuntary Movements
82. Chorea
83. Tremor
84. Treatment of Essential Tremor
85. Treatment of Parkinson's Disease
86. Treatment of Dystonia
87. Treatment of Tics
88. Electromyography and Nerve Conduction Studies
89. Distal Symmetric Polyneuropathy
90. Demyelinating Neuropathies
91. Paraprotein-Associated Neuropathies
92. Mononeuropathy Multiplex
93. Carpal Tunnel Syndrome
94. Brachial Plexus Syndromes
95. Lumbosacral Plexus Syndromes
96. Motor Neuron Disease
97. Myasthenia Gravis: Diagnosis
98. Myasthenia Gravis: Treatment
99. Myopathy
100. Myotonia
101. Rhabdomyolysis
102. Glioma
103. Meningioma
104. Paraneoplastic Syndromes
105. Encephalitis
106. Acute Meningitis
107. Subacute and Chronic Meningitis
108. Tuberculosis Affecting the Nervous System
109. Neurosyphilis
110. Lyme Disease Involving the Nervous System (Neuroborreliosis)
111. Optic Neuritis
112. Treatment of Multiple Sclerosis
113. Transverse Myelitis
114. Neurosarcoidosis
115. Autoimmune Encephalitis
116. White Matter Lesions on Magnetic Resonance Imaging
117. Ring-Enhancing Lesions on Magnetic Resonance Imaging
118. Sellar Lesions on Magnetic Resonance Imaging
119. Cerebellopontine Angle Mass Lesions on Magnetic Resonance Imaging

Appendix 1: Additional Tables
Appendix 2: CIWA-Ar Protocol; NIH Stroke Scale